Screening protocols (aldosterone-to-renin ratio) are recommended for a selective subgroup, e.g., in cases with standard therapy-resistant hypertension, high blood and hypokalemia, hypertension onset at <40 years, people with a family history of hypertension or stroke at a young age, atrial fibrillation, and incidental adenoma. This evidence concerns the gene REN and hypertensive disorder.